UBS Group AG - IMMUNE PHARMACEUTICALS INC ownership

Back to all holdings Add to watchlist

IMMUNE PHARMACEUTICALS INC's ticker is IMNPQ and the CUSIP is 45254C200. A total of 1 filers reported holding IMMUNE PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
UBS Group AG ownership history of IMMUNE PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2018$0
-100.0%
5
-100.0%
0.00%–
Q1 2018$5,000
-90.0%
15,648
-82.1%
0.00%–
Q4 2017$50,000
+400.0%
87,514
+1233.6%
0.00%–
Q3 2017$10,000
+11.1%
6,562
+128.9%
0.00%–
Q2 2017$9,000–2,867–0.00%–
 Download
Other shareholders
IMMUNE PHARMACEUTICALS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Virtu Financial LLC 24,681$14,0000.00%
VANGUARD GROUP INC 415,518$237,0000.00%
UBS Group AG 87,514$50,0000.00%
Advisor Group, Inc. 3,750$2,0000.00%
BANK OF AMERICA CORP /DE/ 21,594$12,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 22,355$12,0000.00%
DEUTSCHE BANK AG\ 4$00.00%
CREDIT SUISSE AG/ 23,504$14,0000.00%
MORGAN STANLEY 54$00.00%
BlackRock Inc. 568$00.00%
View complete list of IMMUNE PHARMACEUTICALS INC shareholders